Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine

被引：0
|
作者：
Ralf Buettner
Le Xuan Truong Nguyen
Corey Morales
Min-Hsuan Chen
Xiwei Wu
Lisa S. Chen
Dinh Hoa Hoang
Servando Hernandez Vargas
Vinod Pullarkat
Varsha Gandhi
Guido Marcucci
Steven T. Rosen
机构：
[1] City of Hope Medical Center,Hematology Malignancies Research Institute, Gehr Family Center for Leukemia Research
[2] City of Hope Medical Center,Integrative Genomics Core, Beckman Research Institute
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
来源：
Journal of Hematology & Oncology | / 14卷
关键词：
Acute myeloid leukemia; Oxidative phosphorylation; Fatty acid oxidation; Nucleoside analog; Metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient
    Niscola, Pasquale
    Mazzone, Carla
    Fratoni, Stefano
    Ardu, Nicolina Rita
    Cesini, Laura
    Giovannini, Marco
    Ottone, Tiziana
    Anemona, Lucia
    Voso, Maria Teresa
    de Fabritiis, Paolo
    ACTA HAEMATOLOGICA, 2023, 146 (05) : 408 - 412
  • [42] Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy
    Sato, Honami
    Kobayashi, Takahiro
    Kameoka, Yoshihiro
    Teshima, Kazuaki
    Watanabe, Atsushi
    Yamada, Masahiro
    Yamashita, Takaya
    Noguchi, Shinsuke
    Michisita, Yoshihiro
    Fujishima, Naohito
    Kuroki, Jun
    Takahashi, Naoto
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (04) : 481 - 492
  • [43] The efficacy and safety of venetoclax and azacytidine combination treatment in patients with acute myeloid leukemia and myelodysplastic syndrome: systematic review and meta-analysis
    Du, Yufeng
    Li, Chunhong
    Yan, Jinsong
    HEMATOLOGY, 2023, 28 (01)
  • [44] Co-Targeting c-Myc and Bcl-2 by Oral Small Molecule Combination of WBC100 and Venetoclax Effectively Controls Acute Myeloid Leukemia in Preclinical Models
    Wang, Ping
    Li, Mengyuan
    Zheng, Shuwen
    Zhuang, Haifeng
    Zhou, Hong
    Gong, Qinyuan
    Wu, Zhaoxing
    Zhang, Xuzhao
    Xu, Rongzhen
    ADVANCED THERAPEUTICS, 2023, 6 (09)
  • [45] Concurrent Diagnosis of Acute Myeloid Leukemia and Symptomatic COVID-19 Infection: a Case Report Successfully Treated with Azacitidine-Venetoclax Combination
    Taurino, Daniela
    Frigeni, Marco
    Grassi, Anna
    Cavallaro, Gianluca
    Salmoiraghi, Silvia
    Spinelli, Orietta
    Rambaldi, Alessandro
    Lussana, Federico
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2021, 13
  • [46] Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience
    De Bellis, Eleonora
    Imbergamo, Silvia
    Candoni, Anna
    Lico, Albana
    Tanasi, Ilaria
    Mauro, Endri
    Mosna, Federico
    Leoncin, Matteo
    Stulle, Manuela
    Griguolo, Davide
    Pravato, Stefano
    Trentin, Livio
    Lazzarotto, Davide
    Di Bona, Eros
    Bassan, Renato
    Lucchini, Elisa
    Poiani, Monica
    Palmieri, Clara
    Zaja, Francesco
    LEUKEMIA RESEARCH, 2022, 114
  • [47] Optimizing venetoclax dose in combination with low intensive therapies in elderly patients with newly diagnosed acute myeloid leukemia: An exposure-response analysis
    Agarwal, Suresh
    Gopalakrishnan, Sathej
    Mensing, Sven
    Potluri, Jalaja
    Hayslip, John
    Kirschbrown, Whitney
    Friedel, Anna
    Menon, Rajeev
    Salem, Ahmed Flamed
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 464 - 473
  • [48] Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2)
    Atalay, Figen
    Atesoglu, Elif Birtas
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 (01) : 46 - 53
  • [49] Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2)
    Figen Atalay
    Elif Birtaş Ateşoğlu
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 : 46 - 53
  • [50] Phase IB OMNIVERSE Trial: Safety and Tolerability of Oral Azacitidine (Oral-AZA) in Combination With Venetoclax (VEN) for Treatment of Acute Myeloid Leukemia (AML)
    Fleming, Shaun
    Roboz, Gail J.
    Fathi, Amir T.
    Zhang, Tian Y.
    Wei, Andrew
    Carraway, Hetty E.
    Holes, Leanne
    Petrlik, Erica
    Prebet, Thomas
    Menezes, Daniel L.
    Bluemmert, Iryna
    Sun, Hao
    Ravandi, Farhad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S293 - S293
12345